EIF2AK3 and neoplasm: At such high concentrations, the inhibitor is no longer selective (Atkins et al., 2013; Rojas-Rivera et al., 2017) and diverse ISR markers such as Asns were elevated despite PERK being inhibited in the pancreas as well as in human tumor xenografts (Atkins et al., 2013).